Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Oligonucleotide Column

Agilent Technologies

The AdvanceBio oligonucleotide column is a high-pH, stable, superficially porous particle-based liquid chromatography column for oligonucleotide analysis. It builds on the innovations in superficially porous silica-based columns for biomolecule ...

Next-Generation Sequencing Panel

Oxford Gene Technology

The SureSeq™ Myeloid Panel is a highly-sensitive next-generation sequencing (NGS) panel that is able to detect mutational changes in 25 genes in one comprehensive assay. The panel replaces the existing procedure of sequential analysis ...

hiPSC Generation Platform

Lonza

The L7™ PBMC Reprogramming Bundle fits seamlessly into the existing L7 workflow to allow researchers to reprogram peripheral blood mononuclear cells (PBMCs) for use in downstream experiments. Because of its series of reagents and proto...

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »